MARKET

Select Market Data Region

- JP
  
  Language
  
  ENGLISH THAI JAPANESE VIETNAMESE
- Sign in

FREE

One-click sign-up, free access to advanced features

Get personalized investment ideas from AI Coach, manage and analyze your own Portfolio & Watchlist, and receive dedicated support when you need account assistance.

Continue with Facebook

{{entry.stock}}
{{entry.security_name}}

{{user.social_name}}

Stock not found.

User not found.

July 28, 2026 01:17 AM finance.yahoo.com Positive

Top Midday Decliners

MPLT NVDA YYAI

MapLight Therapeutics' (MPLT) shares tumbled 68% even after the company said its phase 2 trial of ML

PREMIUM

Upgrade to read this MT Newswires article and get so much more.

A Silver or Gold subscription plan is required to access premium news articles.

Upgrade

Already have a subscription? Sign in

Read original source

Top Watch

US stock ideas Plan your wealth